Haizheng Pharmaceutical announced that Zhejiang Haizheng Animal Health Products Co., Ltd., a holding subsidiary of the company, has received an approval document for telmisartan oral solution veterinary drug product approved by the Ministry of Agriculture and Rural Affairs. The approval number is valid from October 8, 2026 to October 7, 2031. The product is used to treat proteinuria caused by chronic kidney disease in cats. This approval will enrich the company's product structure and promote the strategic layout of the pet medicine sector. There is uncertainty about product launch and sales.

Zhitongcaijing · 2d ago
Haizheng Pharmaceutical announced that Zhejiang Haizheng Animal Health Products Co., Ltd., a holding subsidiary of the company, has received an approval document for telmisartan oral solution veterinary drug product approved by the Ministry of Agriculture and Rural Affairs. The approval number is valid from October 8, 2026 to October 7, 2031. The product is used to treat proteinuria caused by chronic kidney disease in cats. This approval will enrich the company's product structure and promote the strategic layout of the pet medicine sector. There is uncertainty about product launch and sales.